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Objective: To reassess the occurrence of verocytotoxin-producing Escherichia coli (VrEC) in French hemolytic uremic 
syndrome (HUS) patients. 
Methods: From March 1991 to January 1995, direct detection of verotoxin genes (VT) by the polymerase chain reaction 
(PCR) was performed on stool samples from 169 patients suffering from HUS. 
Results: Fifty-one were PCR positive (30.1%); one was positive for the VT1 gene and the others for the VT2 gene. VTEC 
was isolated from only 32 of the 51 PCR-positive samples. E. coli0157:H7 was isolated from five patients. E. coliO111 
was isolated from seven patients during an outbreak of HUS. Among the other Vr2 E. coli strains, only four were 
serotypable. Of the 51 PCR-positive stools, 19 were culture negative for VrEC. 
Conclusions: This study provides evidence that in France E. coli0157 and other VTEC serotypes are involved in HUS. 
Key words: Hemolytic uremic syndrome (HUS), verocytotoxin-producing Escherichia co/i(VTEC), verotoxin genes (VT), 
polymerase chain reaction (PCR). 
Verocytotoxin (VT)-producing Escherichia coli (VTEC) 
is an emerging cause of diarrhea and hemorrhagic 
colitis, and 2-7% of persons infected by VTEC develop 
the hemolytic uremic syndrome (HUS) [1,2]. VTEC 
infections are fiequent in North America [l], where 
several outbreaks have been reported, making VTEC- 
related HUS a serious public health problem [2], and 
also in Argentina [3] and the UK [4]. In North 
America, E. Cali 0157:H7 is the most common sero- 
type of VTEC isolated from stools of patients with 
HUS and accounts for 40-70% of VTEC infections 
[1,2,5]. In routine clinical practice, E. coli 0157:H7 
is easily recovered fiom stool samples on sorbitol 
MacConkey agar. However, VTEC strains other than 
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0157 may cause similar diseases and, at present, screen- 
ing for shch pathogens in the laboratory is difficult, 
because differential markers are not easily available 
[6,7]. In France, the first cases ofVTEC infections have 
been reported more recently, and only six VTEC- 
related HUS patients were observed beetwen 1987 and 
1989 in the French multicenter study [8]. The aim of 
the present work was to  reassess the occurrence of 
VTEC in French HUS patients. Here we report new 
data based on the use of PCR [8,9] for the screening 
of VT genes dxectly in stools &om HUS patients, as 
compared with VTEC isolation. 
METHODS 
From March 1991 to January 1995, we used PCR for 
the direct detection of VT genes in stool samples 
obtained fiom 169 patients less than 15 years of age, 
suffering fiom HUS. Patients came from the different 
regions of France. Each stool sample was submitted to 
the PCR assay we described previously [lo], using two 
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pairs of VT1- and VT2-specific oligonucleotide primers 
dxecting the amplification of 149-bp and 164-bp 
fragments from the VTI and VT2 genes, respectively. In 
our assay, reliability is ensured by the use of an internal 
control which consists of a plasmid containing the VTi 
gene in which we introduced an 11-bp deletion by 
PCR-mediated mutagenesis [ 101. Thls control detects 
any eventual PCR failure caused by the fact that stool 
products were analyzed by agarose gel electrophoresi Tsamples may contain substances that inhibit PCR. 
and ethldium bromide staining (Figure 1). Two control 
strains have been used to evaluate the specificity of 
the two sets of primers: a VTI- and VTz-producing 
E. coli 0157:H7 and a Shigella dysenteriae type 1 strain 
were obtained fiom A. D. O’Brien. The sizes of the 
amplified products were as predicted from the design of 
the primers [lo]. Concurrently, each stool specimen 
was tested for Salmonella, Shigella, Ersinia and Campylo- 
bacter species by standard methods. Additionally, a 
sorbitol MacConkey agar plate was inoculated in order 
to isolate E. coli 0157:H7. Colonies were identified as 
E. coli by standard biochemical tests (API20E system). 
Sorbitol-negative isolates were serotyped by slide 
agglutination with an antiserum to 0157. Sorbitol- 
positive colonies were serogrouped using antisera €or E. 
coli somatic 0 antigens (026, 05,  086,  0111, 0114, 
0119, 0124, 0125, 0126, 0127, 0128, 0142), 
corresponding to the most fiequent serotypes of enterc- 
pathogenic and enteroinvasive E. coli strains in Europe. 
RESULTS 
In our study, 51 of the 169 stool samples were PCR 
positive (30.1%). One was positive for the VTI gene 
and the others for the VT2 gene. PCR inhibition was 
observed in 21 out of 169 samples, probably due to 
bloody stools. In such cases, stool samples were sub- 
mitted to serial tenfold dilutions in sterile water, 
allowing us to give a positive or a negative result, and 
three of these samples were positive for the VT2 gene. 
In contrast, VTEC strains were isolated in only 32 
of the 169 samples (18.9%). All these VTEC strains 
were isolated from PCR-positive stool samples. E. coli 
0157:H7 was isolated in five patients whose stools 
were PCR positive for the VT2 gene, and the five 
strains were VT2-positive by the same PCR method 
[8].  Seven VTz-producing strains of E. coli 0111 were 
isolated in seven patients fiom the same area in France 
(Oise), during an outbreak of HUS [ll]. Other V T 2 -  
producing E. coli strains were isolated from 20 patients: 
two strains were serotyped as 0126, two strains were 
serotyped as 0 2 6  and 16 could not be serotyped with 
the routine procedures. Only one E. coli strain carried 
the VTI gene; the strain was non-typeable. The 118 
PCR-negative stool samples were also culture negative 
for the other enteric pathogens that were sought. 
DISCUSSION 
The present study provides evidence that in France 
E. coli 0157 and other VTEC serotypes are involved in 
HUS, as in other European countries where sporadic 
cases of VTEC infection and small outbreaks have also 
been described [12-141. In our study, PCR on stool 
samples was more sensitive than VTEC isolation (30% 
versus 18.9%). Direct PCR on stool samples seems to 
be a very useful method for the rapid screening of total 
enteric flora and is well suited to the definitive diagnosis 
Figure 1. PCR analysis of the VTI and V T 2  genes in stool samples, Lane 1: 0157:H7 VT1 + VTa-producing E. coli. Lanes 
2 to 5, stools of HUS patients: lane 2, VTI gene; lanes 3 and 4, VT2 gene; lane 5, no VT genes. Lane 6: stools of a healthy 
chld. Lane 7: DNA size marker V (Boerhinger Mannheim, Mannheim, FRG). IC = internal control. 
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of infection and to large epidemiologic studies. The 
treatment of VTEC infection rests on the optimal 
management of physiologic complications. The role of 
antibiotics is questionable. Indeed, the use of anti- 
biotics, prior to the onset of symptoms, is considered 
to be a risk factor in the development of HUS. The 
mechanisms by which antibiotics increase this risk of 
developing complications may involve the enhance- 
ment of toxin production by overgrowth of VTEC 
and/or antibiotic induced release of VT [l, 151. 
Clearly, the epidemiology of VTEC-related HUS 
should be revisited by introducing the PCR test in the 
diagnostic procedure. Precise epidemiologic data are 
important to gather, because they could be used to 
increase the clinician’s awareness of the disease. Indeed, 
the rather small percentage of positive diagnoses, even 
with the use of the PCR test, probably results from the 
fact that 72% of stool samples were obtained only 8 or 
more days afier the onset of gastrointestinal symptoms. 
Early recognition of the disease would probably permit 
better management of the patients. 
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